Micro Current Stimulation (MCS) therapy
Micro Current Stimulation (MCS) therapy is perhaps the most promising treatment currently being investigated for dry age-related macular degeneration. This is a non-surgical procedure, which is the promotion of nerve fibers in the macula and a current very low with a device approved by the FDA on battery power. The current is supplied deposited with different electrical frequencies through electrodes on the closed eyelids. Treatmentdoes not cause discomfort or pain and is twice a day. While a very effective form of treatment is the MCS therapy is no cure for macular degeneration and must continue for the life of the patient. Overall, no side effects or adverse reactions associated with this process were observed. Micro current technology stimulation to the point where people learn their own micro-electrical stimulation therapy can be considered a residential unit progressed. In many cases, a patientMCS undergoing treatment will experience an improvement in vision in four days. For people with a severe form of the disease, it may take several months.
Human cells are no different than batteries. They sometimes have lower energy can be saved or to maintain power. The micro-current therapy offers the charm of the cells 'energy' must be similar to charging a battery. Studies have also shown that the MCS therapy increases the flow of blood microcirculation,concentrations of ATP stimulated an increase in amino acids and concentrations of nutrients into cells.
Each body cell has an electrical charge. It is believed that part of what causes macular degeneration is a waste of energy source in the cell, or loss of electric charge. Just like a flashlight does not work without a charged battery to work, the photoreceptors of the retina can not function without a source of energy. MCS therapy is considered to increase energy sourcewithin the cell.
Macular Degeneration Foundation provides preliminary pre-clinical studies through pioneering ophthalmologists and researchers can view the electrical stimulation therapy, visual acuity, sharpness and color vision in 68 percent of patients improve with macular degeneration dry and 58 percent of respondents with the wet form. Reports from Russia indicate similar benefits.
A study conducted by Dr. J. Allen and Dr. Michael D. Leland under Nutritional published by MerrellIn addition, electrical stimulation and age-related macular degeneration showed that 60 percent of patients showed improvement in visual acuity after a combination therapy of micro-electrical stimulation and dietary supplements.
Drs Grace Halloran and August L. Reader studied with thirty people, in general, do not treat diagnosed eye diseases including macular degeneration, retinitis pigmentosa, CMV retinitis, and diabetic retinopathy. Patients were treated with aA combination of micro-electrical stimulation therapy and dietary supplements. Overall, significant increase in visual acuity of vision led to the majority and clearly establishes the safety of the combination of MCS therapy and dietary supplements.
Frequently Asked Questions about MCSTherapy ...
How does MCS (TM) Therapy?
In general, the electrical current gently wakes up the cells from sleep and stimulates the healing process. In short, cellssuch as batteries. When energy is low or runs out, the lights go out. MCS therapy changing the electrical charge of the cells in the eye to promote healing and regeneration.
The second way the therapy works, the ability of cells to increase to get rid of waste. A cell with "stuck" waste products is a dead cell and impair cellular communications in the region, where it is. The cells must take in nutrients and eliminate waste, as allother living beings. The energy provided by MCS therapy stimulates the cells of vital and less sluggish.
The third possibility MCS therapy works, is driven by an increase in blood flow in the area. By increasing blood flow in the range of cells and tissues are nourished, refreshed and increases the oxygen supply.
MCS therapy is safe?
No side effects or visible adverse effects associated with this treatment were. No increase in conversion to the wet form of AMD was foundthose who have been treated.
What is the treatment?
MCS therapy can be administered in a doctor's office or a treatment unit at home. Even if you start the treatment in a medical study, prolonged treatment with a treatment device at home is to keep to an improvement in vision and poor need to think of AMD.
After learning to self-administer treatment to treatment in the comfort of conduct at home with home treatment device. This iseasy to learn and use. After starting the treatments will continue with treatments twice a day. Each treatment lasts 6 to 12 minutes. Who has had the therapy, his vision to deteriorate.
How much can I expect an improvement in vision therapy MCS?
The results have been remarkable, with more than 68% of people with dry AMD treated show a statistically significant improvement in one or both eyes and 58% of people with wet AMD showsImprovement. 52% of patients experience an improvement of two or more lines with the standard Snellen chart visual acuity measured.
Why does my optometrist or ophthalmologist to know about MCS Therapy?
Most eye doctors in practice today have been told that she had macular degeneration, an incurable disease and that nothing can be done to restore a damaged retina to a healthy state. It 's also interesting to note that most doctors now in practice have beentrained to believe that food supplements are a waste of time and money. After 20 years they have finally admitted it was wrong on vitamins. Medicine as a profession is to change slowly or admit their mistakes.
Micro-electric stimulation therapy is currently used by most of the vitamins so doctors have been seen 20 years ago, is considered a therapy "unconventional". While small studies in the literature that the efficacy of MCS has been published,Although there have been major scientific studies have been published in traditional journals. These large-scale studies are what most doctors depend on to guide them in their recommendations to patients.
Several large-scale studies are underway or are being developed and should prove the efficacy of MCS for all. However, it takes 2 to 4 years and millions of dollars in research funds to complete their studies. Meanwhile, there areno reason that this option should be given to patients. The first reports were positive in 65 to 90 percent of patients treated, there are no side effects or contraindications, treatment is relatively inexpensive, and there is no alternative treatment. Why not a patient with an illness otherwise "incurable" try this option?
The scientific evidence for medical treatment for MCS ...
How does the MCS therapy?
MCS therapy works by increasingintracellular ATP (adenosine triphosphate) concentrations, enhancing protein synthesis and stimulation of the cells' ability to absorb nutrients (Ngok Cheng, MD). It is believed that through these mechanisms, MCS therapy improves RPE efficiency and, therefore, can be recovered and / or improve macular function.
ATP is synthesized in the mitochondrial respiration in a process known as the Krebs cycle, the sequence of reactions in the mitochondria that complete oxidation of glucose. KrollWarriors of the age-related changes in mitochondrial metabolism, which showed a decrease in synthase. Guerrieri has gone further to show functional and structural differences of mitochondrial F0F1 ATP synthase complex in aging rats. It is believed that many diseases of the retina, at least in part, to a decrease in mitochondrial function and the consequent decrease of intracellular ATP. This reduction in mitochondrial function resulting from damage caused by free radicals andmutation of mtDNA (mitochondrial DNA).
It 's interesting to note the genetic link between ATP and retinal disease. ATP synthase (ATPase) is an enzyme that catalyzes the synthesis of ATP. A genetic defect in the ATPase 6 gene has now been raised in retinitis pigmentosa.
What is the difference between mortgage micro-currents, and other devices on the market?
Research by Cheng showed a very significant difference between the types of electrical installationsStimulators known as TENS devices and those classified as micro-current stimulators. Research has shown that the treatment was carried out with currents below 1000 micro-amps (less than 1 milli-amp) has a higher absorption of 75% to 400% of amino acids and an increase in intracellular ATP. In those treated with more than 1,000 micro-amps (more than 1 milli ampere), was in fact the amount of these substances, which are often less depressed compared with untreated controls. It 's very important to note,that TENS devices less expensive outside the safe and effective milliampere range and processed to levels much higher, some up to 80 mA. This is potentially dangerous and can lead to a reduction of intracellular ATP and the interruption of the Krebs cycle, with the reverse effect of MCS (TM) therapy. Micro current stimulator is 10 times the circuit of a standard therapeutic electrical stimulator and controlled treatment of the safe area to avoid milli amperes. Also, make sure that everyDevice, you can use is approved by the FDA. Many not on the market.
What is the legal status of MCS therapy with the FDA?
In the USA, governs the Food and Drug Administration (FDA) the sale of medical devices (an example is the use of lasers for LASIK surgery is used). Before a medical device in the United States illegally, the person or company selling the device will need to obtain from the FDA for sale. To obtain approval, must submit evidence that the deviceis fairly safe and effective for any purpose, the "Note". Relieve the symptoms of chronic intractable pain and as adjunctive therapy in the treatment of postoperative wound pain problems: Micro current stimulators were cleared in order for the indication. Once the FDA has approved a medical device, a doctor may decide to use the device for other indications if the doctor considers it in the best interest of the patient. The use of a device approved forother than the FDA-approved indication is called "off-label use." MCS therapy is considered "off-label use."
Dr. Edward Paul - America's Eye Doctor - http://www.DrEdwardPaul.com
ไม่มีความคิดเห็น:
แสดงความคิดเห็น